Shanghai InnoStar Bio-tech Co., Ltd. (SHA:688710)
China · Delayed Price · Currency is CNY 89.89
-5.36 (-5.63%)
At close: Aug 24, 2026
SHA:688710 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 21, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 12,673 | 6,224 | 5,006 | - | - | - | |
Market Cap Growth | 114.38% | 24.33% | - | - | - | - |
Enterprise Value | 11,500 | 5,133 | 3,782 | - | - | - |
Last Close Price | 89.89 | 44.15 | 35.22 | - | - | - |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 21, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 531.43 | - | 33.88 | - | - | - |
PS Ratio | 14.06 | 7.67 | 4.39 | - | - | - |
PB Ratio | 5.27 | 2.64 | 2.08 | - | - | - |
P/TBV Ratio | 5.60 | 2.80 | 2.19 | - | - | - |
P/OCF Ratio | 33.45 | 61.40 | - | - | - | - |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 21, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 12.76 | 6.33 | 3.31 | - | - | - |
EV/EBITDA Ratio | 141.70 | 244.18 | 18.98 | - | - | - |
EV/EBIT Ratio | - | - | 25.45 | - | - | - |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 21, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.06 | 0.05 | 0.10 | 0.15 | 0.17 | 0.39 |
Debt / EBITDA Ratio | 2.36 | 2.54 | 1.01 | 0.94 | 1.19 | 1.89 |
Debt / FCF Ratio | 1.48 | - | - | - | 1.86 | 6.68 |
Net Debt / Equity Ratio | -0.51 | -0.50 | -0.47 | -0.56 | -0.70 | -0.47 |
Net Debt / EBITDA Ratio | -39.26 | -55.72 | -5.71 | -3.87 | -5.61 | -2.54 |
Net Debt / FCF Ratio | -13.68 | 35.96 | 2.96 | 13.85 | -7.60 | -8.01 |
Asset Turnover | 0.25 | 0.25 | 0.38 | 0.39 | 0.39 | 0.46 |
Inventory Turnover | 1.73 | 1.76 | 1.92 | 1.26 | 1.21 | 1.19 |
Quick Ratio | 2.09 | 2.28 | 3.08 | 1.65 | 1.65 | 1.03 |
Current Ratio | 2.84 | 3.06 | 3.81 | 2.25 | 2.23 | 1.64 |
Return on Equity (ROE) | -0.01% | -0.44% | 6.76% | 11.78% | 10.76% | 18.65% |
Return on Assets (ROA) | -0.64% | -0.78% | 3.10% | 4.37% | 3.87% | 5.22% |
Return on Invested Capital (ROIC) | -2.85% | -3.31% | 12.83% | 27.84% | 27.39% | 40.81% |
Return on Capital Employed (ROCE) | -1.30% | -1.60% | 5.60% | 10.00% | 8.00% | 10.30% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 21, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 0.19% | -0.49% | 2.95% | - | - | - |
FCF Yield | 1.68% | -0.52% | -7.67% | - | - | - |
Dividend Yield | - | - | 0.91% | - | - | - |
Payout Ratio | 189.18% | - | 0.15% | 0.01% | 23.83% | 12.83% |
Buyback Yield / Dilution | -10.19% | -18.27% | -10.98% | -9.26% | -31.77% | -24.09% |
Total Shareholder Return | -10.19% | -18.27% | -10.07% | -9.26% | -31.77% | -24.09% |